U.S. medical device industry representatives, for now, appear to be taking a wait and see approach as President Donald Trump’s administration wrangles over trade policy and threatens tariffs against China. The status of China tariffs on medical devices is unknown at this time as the Trump administration continues to make changes to its trade policies with China.
The U.S. is set to impose a 25% tariff on about $50 billion worth of goods imported from China containing industrially significant technology, including those related to the “Made in China 2025” program. The final list of imports will be announced by June 15.
White House officials recently put out a statement that said China has been taking advantage of the American economy and that is not part of the fair and reciprocal trade that the U.S. expects. According to the White House, China has previously imposed higher tariffs on U.S. exports than what the U.S. imposes on China.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.